Pfizer, Circle in macrocycle deals

Circle Pharma Inc. (San Francisco, Calif.) announced two collaborations with Pfizer Inc. (NYSE:PFE) to design and develop macrocyclic peptides against two undisclosed Pfizer targets. Circle will develop the peptides using computational design algorithms, and Pfizer will test them in undisclosed indications. ...